|Podcasts|June 18, 2009
Rewards for Subjects, an Ethical Dilemma?
Advertisement
Rewards for Subjects, an Ethical Dilemma?
Felix Gyi, PharmD, MBA, CEO of Chesapeake Research Review discusses ethical rewards for patients in clinical studies and how the relationships between pharma and health care professionals affects subject recruitment and retention.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE SummitFebruary 7th 2025
The MDR: Navigating Europe’s New Standard for Medical Device SafetyOctober 25th 2022
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
4
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
